Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Change in Accured Expenses (2013 - 2026)

Updated

Ocular Therapeutix's Change in Accured Expenses was $1.47 million in Q2 2026, down 48.2% from $2.84 million a year earlier.

Analysis

Ocular Therapeutix (OCUL) Change in Accured Expenses (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ocular Therapeutix's Change in Accured Expenses was $582,000 through Jun 30, 2026, down 92.2% year-over-year; for FY2025, it came in at $5.25 million, up 44.3% from FY2024.

  • Change in Accured Expenses shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $3.64 million in FY2024 (+370.6%), $773,000 in FY2023 (-53.0%), $1.64 million in FY2022 (-55.8%) and $3.72 million in FY2021 (+60.8%).
  • Quarterly Change in Accured Expenses has moved between -$14.03 million (Q1 2024) and $7.86 million (Q2 2024) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in 1 of the last five quarters, with an average decline of 9.7%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q4 2022 (growth of 930.3%); the worst was Q4 2021 (a decline of 86.6%).
  • Per Business Quant data, OCUL's Change in Accured Expenses in the three quarters before Q2 2026 was -$8.44 million (Q1 2026), $2.18 million (Q4 2025) and $5.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.96 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.20 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 338.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 222.50 Mn
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.47 Mn
Mar 31, 2026 -8.44 Mn
Dec 31, 2025 2.18 Mn
Sep 30, 2025 5.38 Mn
Jun 30, 2025 2.84 Mn
Mar 31, 2025 -5.15 Mn
Dec 31, 2024 4.21 Mn
Sep 30, 2024 5.60 Mn
Jun 30, 2024 7.86 Mn
Mar 31, 2024 -14.03 Mn
Dec 31, 2023 -1.25 Mn
Sep 30, 2023 2.60 Mn
Jun 30, 2023 2.05 Mn
Mar 31, 2023 -2.63 Mn
Dec 31, 2022 1.94 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 -3.05 Mn
Dec 31, 2021 188,000.00
Sep 30, 2021 2.60 Mn
API Access

Ocular Therapeutix Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=OCUL&period=max&api_key=YOUR_API_KEY